The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 18th Jul 2014 07:55

Barclays: Credit Suisse cuts target price from 275p to 235p retaining a neutral rating.Barratt Developments: Liberum Capital reduces target price from 468p to 387p and downgrades to hold.Bellway: Liberum Capital reduces target price from 1900p to 1764p, while leaving its buy recommendation unchanged.Berkeley Group: Liberum Capital cuts target price from 2634p to 2613p retaining a hold recommendation.Bovis Homes Group: Liberum Capital reduces target price from 1034p to 930p and stays with its buy recommendation.Breedon: Jefferies shifts target price from 45p to 47p and reiterates a hold recommendation.British Land: Barclays raises target price from 695p to 936p, while its overweight rating remains unchanged.Burberry Group: Exane upgrades to outperform with a target price of 1700p.bwin.party: Deutsche Bank lowers target price from 110p to 100p and reiterates a hold recommendation.Croda International: Berenberg reduces target price from 2850p to 2700p, while keeping its buy recommendation.Drax Group: UBS moves target price from 790p to 800p and stays with its buy recommendation.GKN: Citi lowers target price from 435p to 410p, while staying with its buy recommendation.Gleeson: Liberum Capital cuts target price from 481p to 466p keeping a buy recommendation.Hays: Credit Suisse lowers target price from 165p to 150p and reiterates an outperform rating.Hikma Pharmaceuticals: Goldman Sachs raises target price from 1800p to 2250p and upgrades to buy.Hochschild Mining: Citi shifts target price from 110p to 116p, but still recommends selling.Howden Joinery: Berenberg initiates with a target price of 390p and a buy recommendation.Lloyds Banking Group: Citi lowers target price from 83p to 80p and retains a neutral rating.ISG: Jefferies shifts target price from 389p to 390p and keeps a buy recommendation.Michael Page: Credit Suisse cuts target price from 530p to 510p and maintains an outperform rating.Persimmon: Liberum Capital reduces target price from 1303p to 1238p and reiterates a hold recommendation.Reckitt Benckiser: Numis initiates with a target price of 5600p and an add rating.Redrow: Liberum Capital cuts target price from 320p to 307p and stays with its buy recommendation.Ricardo: Oriel raises target price to 700p and upgrades from reduce to buy.Robert Walters: Credit Suisse cuts target price from 380p to 360p and stays with its outperform rating.Standard Chartered: Deutsche Bank reduces target price from 1275p to 1160p and maintains a hold recommendation.SThree: Credit Suisse cuts target price from 450p to 420p and downgrades to neutral.Taylor Wimpey: Liberum Capital lowers target price from 132p to 130p maintaining a buy recommendation.Thorntons: Oriel initiates with a target price of 160p and a buy recommendation.William Hill: UBS cuts target price from 420p to 390p and retains a buy recommendation.
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.